We are live on ! Find out more
ADILW

Adial Pharmaceuticals Warrant
ADILW

Delisted

ADILW was delisted on the 27th of July, 2023.

Back to rankings

2 hedge funds and large institutions have $17K invested in Adial Pharmaceuticals Warrant in 2021 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

240% more capital invested

Capital invested by funds: $5K → $17K (+$12K)

0% more funds holding

Funds holding: 2 → 2 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Ameriprise
Ameriprise
Minnesota
+$10.1K
2
WAM
Wolverine Asset Management
Illinois
+$2.89K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
Ameriprise
1
Ameriprise
Minnesota
$11K +$10.1K +15,000 New
WAM
2
Wolverine Asset Management
Illinois
$6K +$2.89K +4,302 +96%
UBS Group
3
UBS Group
Switzerland
– -$3K -4,961 Closed

ADILW Hedge Fund Activity: Q2 2021 in Review

2 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Adial Pharmaceuticals Warrant (ADILW) for Q2 2021, worth a combined $17K — up 240% from $5K a quarter earlier.

Fund positioning in ADILW was balanced in Q2 2021: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was Ameriprise, opening a new position worth an estimated $10.1K. The largest seller was UBS Group, exiting entirely with an estimated $3K sold.

  • 2 institutional investors held Adial Pharmaceuticals Warrant (ADILW) as of Q2 2021, unchanged from Q1 2021.
  • Funds reported $17K of Adial Pharmaceuticals Warrant stock for Q2 2021, up 240% quarter-over-quarter.
  • 1 fund opened new Adial Pharmaceuticals Warrant positions in Q2 2021 and 1 closed out, a net change of 0 holders.
  • The largest Adial Pharmaceuticals Warrant buyer in Q2 2021 was Ameriprise, an estimated $10.1K added.
  • The largest Adial Pharmaceuticals Warrant seller in Q2 2021 was UBS Group, an estimated $3K sold.

Based on aggregated 13F filings for Q2 2021.